JH
Fennec Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Pedmark (Sodium Thiosulfate) | Prevention of Cisplatin-Induced Ototoxicity in pediatric localized solid tumors | Approved |
| Sodium Thiosulfate | Prevention of CIO in newly diagnosed hepatoblastoma (Compassionate Use) | N/A |
Leadership Team at Fennec Pharmaceuticals
RA
Robert Andrade
Chief Financial Officer
PS
Pierre S. Sayad
Chief Medical Officer
TE
Terry Evans
Chief Commercial Officer